Evidence map›Paper›PMID 34862559›Full record

ReviewActa neurochirurgica. Supplement2022

Machine Learning in Neuro-Oncology, Epilepsy, Alzheimer's Disease, and Schizophrenia.

Mason English, Chitra Kumar, Bonnie Legg Ditterline, Doniel Drazin, Nicholas Dietz

Abstract readReview
PubMed Publisher
In one paragraph

Review in Acta neurochirurgica. Supplement, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mason English *Department of Neurological Surgery, University of Louisville, Louisville, KY, USA.
Chitra Kumar *Department of Neurological Surgery, University of Louisville, Louisville, KY, USA.
Bonnie Legg DitterlineDepartment of Neurological Surgery, University of Louisville, Louisville, KY, USA.
Doniel DrazinEvergreen Hospital Neuroscience Institute, Kirkland, WA, USA.
Nicholas DietzDepartment of Neurological Surgery, University of Louisville, Louisville, KY, USA. nick.dietz@uoflhealth.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Applications of machine learning (ML) in translational medicine include therapeutic drug creation, diagnostic development, surgical planning, outcome prediction, and intraoperative assistance. Opportunities in the neurosciences are rich given advancement in our understanding of the brain, expanding indications for intervention, and diagnostic challenges often characterized by multiple clinical and environmental factors. We present a review of ML in neuro-oncology, epilepsy, Alzheimer's disease, and schizophrenia to highlight recent progression in these field, optimizing machine learning capabilities in their current forms. Supervised learning models appear to be the most commonly incorporated algorithm models for machine learning across the reviewed neuroscience disciplines with primary aim of diagnosis. Accuracy ranges are high from 63% to 99% across all algorithms investigated. Machine learning contributions to neurosurgery, neurology, psychiatry, and the clinical and basic science neurosciences may enhance current medical best practices while also broadening our understanding of dynamic neural networks and the brain.

Indexed as

Alzheimer DiseaseEpilepsySchizophreniaHumansMachine LearningTranslational Science, BiomedicalAlzheimer’s diseaseEpilepsyMachine learningNeuro-oncologySchizophrenia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.